MedTrace Logo

Kids Safe and Smokefree (KiSS)

NCT01745393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 327

Last updated 2018-08-08

Study results available
· View outcomes & findings →

Summary

The study's primary aim is to test the hypothesis that an intervention integrating pediatric clinic-level quality improvement with home-level behavioral counseling (CQI+BC) will result in greater reductions in child cotinine (a biomarker of secondhand smoke exposure) and reported cigarettes exposed/day than a clinic-level quality improvement plus attention control intervention (CQI+A). A secondary aim is to test the hypothesis that relative to CQI+A, CQI+BC will result in higher cotinine-verified, 7-day point prevalence quit rate among parents.

Conditions

  • Second Hand Tobacco Smoke
  • Nicotine Dependence

Interventions

BEHAVIORAL

Clinic Quality Improvement + Behavioral Counseling

BEHAVIORAL

Clinic Quality Improvement + Attention Control

Sponsors & Collaborators

Principal Investigators

  • Brad Collins, PhD · Temple University

  • Stephen Lepore, PhD · Temple University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01745393 on ClinicalTrials.gov